EMMA DIZON: Open Payments
NPI 1619240249 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 13 payments from 9 companies in 2025. Trend: 2023 $859 · 2024 $685 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $57 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Lilly USA, LLC | 2 | $32 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
| Corium, LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: Rybelsus, ROTATEQ, MOUNJARO, NEFFY, Azstarys, Auvelity, UBRELVY, Jornay PM.
Industry payments across NY — which companies pay providers there.
